on Mallia Innovations
Mallia Aesthetics Named Innovation Tank Finalist at IMCAS World Congress 2026
Mallia Aesthetics GmbH has been chosen as a finalist for the Innovation Tank competition at the IMCAS World Congress 2026. The event, set to take place from January 29 to 31 in Paris, focuses on dermatology, plastic surgery, and aging science. Mallia will present its sCD83-based innovation, which competes for the “Innovation of the Year” Award.
Prof. Dr. Alexander Steinkasserer will introduce the company's hormone-free 8T3 Essentials Hair Serum and Lash & Brow Serum, both utilizing the proprietary sCD83 protein. This protein activates hair growth through a multimodal mechanism, differing from other treatments by not entering the bloodstream, thus offering a safer alternative for consumers.
The IMCAS World Congress attracts over 20,000 attendees, providing a prominent platform for industry innovations.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Mallia Innovations news